Episurf Medical appointed 4Medicals SRL as its distributor in northern Italy. Earlier this year, the company's Episealer® knee implants were registered and approved for sale in the region.
In its quarterly interim report, Episurf noted progress in the U.S. Investigational Device Exemption clinical trial of the Episealer knee. The list of participating sites is complete, with the majority of sites trained in the surgical technique onsite. Several sites have patients in the pipeline, though Episurf has yet to report first surgeries in the U.S. The timetable for the European sites is slightly behind the U.S. timetable.